Sawai Reports ‘Solid Overall’ Full Year Results Despite Some Misses

Industry Analysts Noted Slip In The Japanese Firm’s Operating Profit

Japan listed 14 drugs
Japan shifts towards more active in addressing drug gap through its policies. (Shutterstock)

More from Earnings

More from Generics Bulletin